Results
1
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
1 companies
Dermapharm Holding
Market Cap: €2.1b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€41.80
7D
3.6%
1Y
24.8%